Skip to main content
. 2022 Dec 1;8(2):e10453. doi: 10.1002/btm2.10453

FIGURE 4.

FIGURE 4

Survival of mice bearing orthotopic ovarian KPCA tumors (1E06 IP). Tumors were allowed to establish for 7 days prior to beginning five daily treatments at 10 μg equivalent of IL‐12 (gray arrows). **indicates a significant increase in median survival relative to dextrose controls evaluated using the Log‐Rank test (p < 0.01). N = 4 Dex; N = 5 IL‐12, NPs